MGROF:OTC-Mustgrow Biologics Corp (USD)

COMMON STOCK | Agricultural Inputs |

Last Closing

USD 0.778

Change

+0.08 (+10.83)%

Market Cap

USD 0.04B

Volume

4.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap
YRAIF Yara International ASA

N/A

USD 7.28B
KNKZF KWS SAAT SE & Co. KGaA

N/A

USD 2.44B
KPLUF K&S AG

N/A

USD 2.10B
BWEL Boswell J G Co

-18.00 (-3.13%)

USD 0.54B
VRDR Verde Resources Inc

N/A

USD 0.24B
MBCF Itafos Inc

-0.05 (-4.27%)

USD 0.22B
WYNSF Wynnstay Group Plc

N/A

USD 0.13B
SGTM National Storm Recovery Inc

N/A

USD 0.07B
GNVR GNVR

N/A

USD 0.04B
KNGW Kenongwo Group US Inc

N/A

USD 0.03B

ETFs Containing MGROF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Agricultural Inputs) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.79% 48% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.79% 46% F 33% F
Trailing 12 Months  
Capital Gain -33.39% 48% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -33.39% 48% F 31% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 269.46% 94% A 90% A-
Dividend Return 269.46% 94% A 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1,545.56% 8% B- 8% B-
Risk Adjusted Return 17.43% 58% F 52% F
Market Capitalization 0.04B 63% D 50% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.